Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | APLNR | P35414 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3741325 | 0.82 | SMN1; SMN2 (0.36) | GAAL3MBTL1SMN1; SMN2APLNRKMT2A | |
| SCHEMBL416167 | 0.79 | APLNR (0.58) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL3004068 | 0.79 | GAA (0.43) | GAAL3MBTL1SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL20711669 | 0.77 | GAA (0.41) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL4206610 | 0.75 | — | — | |
| SCHEMBL20467800 | 0.74 | GAA (0.39) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL12846334 | 0.74 | GAA (0.39) | GAAL3MBTL1SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL13225974 | 0.74 | GAA (0.48) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL13225973 | 0.74 | GAA (0.48) | GAAL3MBTL1KDM4EALDH1A1ALOX15 | |
| SCHEMBL13979304 | 0.74 | APLNR (0.41) | GAAL3MBTL1KDM4EALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5681903-A | REACTING POLYMERIC ALIPHATIC ALKANEDIOL WITH STABLE FREE RADICAL NITROXIDE IN PRESENCE OF NITROGEN OXIDE-GENERATING COMPOUND AND OXIDANT, SEPARATING POLYMERIC ALPHA, OMEGA-DIALDEHYDE AND/OR DIACID | SHELL OIL COMPANY (US) | 1997-10-28 | — | — | US | claimed |
| US-5495045-A | REACTING ALKOXYALKANOL WITH STABLE FREE RADICAL NITROXIDE IN PRESENCE OF CERIUM SALT, NITRITE COMPOUND, POLAR SOLVENT, OXIDANT AND WATER | SHELL OIL COMPANY (US) | 1996-02-27 | — | — | US | claimed |
| US-5488154-A | REACTING ALKOXYALKANE WITH FREE RADICAL NITROXIDE | SHELL OIL COMPANY (US) | 1996-01-30 | — | — | US | claimed |
| US-5391822-A | Reacting corresponding branched alkoxyalkanol with stable free radical nitroxide in presence of nitrogen oxide-generating compound, oxidant and solvent, separating | SHELL OIL COMPANY (US) | 1995-02-21 | — | — | US | claimed |
| US-5380930-A | Reacting alkoxyalkanol with a nitroxide | SHELL OIL COMPANY (US) | 1995-01-10 | — | — | US | claimed |
| US-5352824-A | Oxidation of alkoxyalkanol using stable free radical nitroxide, copper or iron salt and nitrite catalysts in solvent | SHELL OIL COMPANY (US) | 1994-10-04 | — | — | US | claimed |
| US-5336811-A | Reacting corresponding aryl methanol with a free radical nitroxide in the presence of a nitrogen oxide generating compound | SHELL OIL COMPANY (US) | 1994-08-09 | — | — | US | claimed |
| WO-2024005141-A1 | COMPOSITION FOR HOLOGRAPHIC RECORDING MEDIA | 三菱ケミカル株式会社 | 2024-01-04 | — | — | WO | disclosed |
| US-11378881-B2 | Composition for holographic recording medium, cured product for holographic recording medium, and holographic recording medium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-07-05 | — | — | US | disclosed |
| US-20210080826-A1 | COMPOSITION FOR HOLOGRAPHIC RECORDING MEDIUM, CURED PRODUCT FOR HOLOGRAPHIC RECORDING MEDIUM, AND HOLOGRAPHIC RECORDING MEDIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-03-18 | — | — | US | disclosed |
| US-20140349218-A1 | PHOTOSENSITIVE MATERIAL, HOLOGRAPHIC RECORDING MEDIUM AND HOLOGRAPHIC RECORDING METHOD | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD (JP) | 2014-11-27 | — | — | US | disclosed |
| US-8598340-B2 | Spirooxazine radical derivatives and reversible isomerization reaction | NEC CORPORATION (JP) | 2013-12-03 | — | — | US | disclosed |
| US-20130072678-A1 | SPIROOXAZINE RADICAL DERIVATIVES AND REVERSIBLE ISOMERIZATION REACTION | NEC CORPORATION (JP) | 2013-03-21 | — | — | US | disclosed |
| US-5681903-A | REACTING POLYMERIC ALIPHATIC ALKANEDIOL WITH STABLE FREE RADICAL NITROXIDE IN PRESENCE OF NITROGEN OXIDE-GENERATING COMPOUND AND OXIDANT, SEPARATING POLYMERIC ALPHA, OMEGA-DIALDEHYDE AND/OR DIACID | SHELL OIL COMPANY (US) | 1997-10-28 | — | — | US | disclosed |
| US-5495045-A | REACTING ALKOXYALKANOL WITH STABLE FREE RADICAL NITROXIDE IN PRESENCE OF CERIUM SALT, NITRITE COMPOUND, POLAR SOLVENT, OXIDANT AND WATER | SHELL OIL COMPANY (US) | 1996-02-27 | — | — | US | disclosed |
| US-5488154-A | REACTING ALKOXYALKANE WITH FREE RADICAL NITROXIDE | SHELL OIL COMPANY (US) | 1996-01-30 | — | — | US | disclosed |
| US-5391822-A | Reacting corresponding branched alkoxyalkanol with stable free radical nitroxide in presence of nitrogen oxide-generating compound, oxidant and solvent, separating | SHELL OIL COMPANY (US) | 1995-02-21 | — | — | US | disclosed |
| US-5380930-A | Reacting alkoxyalkanol with a nitroxide | SHELL OIL COMPANY (US) | 1995-01-10 | — | — | US | disclosed |
| US-5352824-A | Oxidation of alkoxyalkanol using stable free radical nitroxide, copper or iron salt and nitrite catalysts in solvent | SHELL OIL COMPANY (US) | 1994-10-04 | — | — | US | disclosed |
| US-5336811-A | Reacting corresponding aryl methanol with a free radical nitroxide in the presence of a nitrogen oxide generating compound | SHELL OIL COMPANY (US) | 1994-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072678-A1 | SPIROOXAZINE RADICAL DERIVATIVES AND REVERSIBLE ISOMERIZATION REACTION | CYP4Z1, POR, CYP3A5 | GAA 4323/4885L3MBTL1 4883/4885SMN1; SMN2 3967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.